• DaVita annual report for 2025 highlighted progress in integrated kidney care, citing improved clinical outcomes and earlier-than-expected profitability for the value-based program.
• International expansion accelerated with completion of Brazil acquisition, extending footprint to 585 outpatient centers across 14 countries serving about 94,500 patients.
• US dialysis franchise remained core business, treating about 200,500 patients across 2,657 outpatient centers, with home dialysis adoption cited as a key strategic priority.
• Shareholder returns stayed central to capital strategy, with USD 1.79 billion deployed for share repurchases during 2025.
• Operations continued through an April cybersecurity incident, with contingency plans used to maintain care across more than 3,000 dialysis centers worldwide.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DaVita Inc. published the original content used to generate this news brief on May 04, 2026, and is solely responsible for the information contained therein.